NeuBase Therapeutics, Inc. Made Headway

NeuBase Therapeutics, Inc. (NBSE:NASDAQ) shot up at $2.38, a gain of 107%. On Wed, Sep 06, 2023, NBSE:NASDAQ hit a New 2-Week High of $2.38. The stock appeared on our News Catalysts scanner on Wed, Sep 06, 2023 at 01:30 PM in the 'MISCELLANEOUS' category. From Wed, Aug 23, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days

The stock spiked on Wed, Sep 06, 2023 at $3.16 with a volume of 105M+.

About NeuBase Therapeutics, Inc. (NBSE:NASDAQ)

Ohr Pharmaceutical Inc is a US-based pharmaceutical company which focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. The lead product of the company is topical Squalamine is a novel therapeutic product which provides non-invasive therapy to improve visual outcomes. Its product pipeline includes SQUALAMINE LACTATE OPHTHALMIC SOLUTION 0.2%, SKS sustained release ocular drug delivery platform technology, Animal Model for Dry-AMD, and Non-Ophthalmology Assets.